Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2024

Jan 4, 2024

33018_dirs_2024-01-04_3f72d50f-3544-4237-a967-a6696e53ba5e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2024-01-02

Reporting Person: Kuhn Thomas R. (Director, Vice Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-01-02 Common Stock A 3898 Acquired 3898 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-01-02 Stock Option (Right to Buy) $33.62 A 58998 Acquired 2034-01-02 Common Stock (58998) Direct

Footnotes

F1: The restricted stock vests in full on August 7, 2024.

F2: Options awarded in connection with director's appointment to the Board as Vice Chairman. For further information see the Anterix Inc. Form 8-K filed with the Securities Exchange Commission on January 4, 2024.

F3: 1/3rd of the option shares vest and become exercisable on January 2, 2025, with the remaining option shares vesting in 2 equal annual installments thereafter.